| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Latigo Biotherapeutics, Inc. (LTGO) have been net buyers, picking up 140,000 shares worth roughly $2.5M on balance.
Counted by filing, the last 12 months brought 1 open-market purchase by 1 insider worth about $2.5M and no sales. There were none in the 12 months before that either.
Funds and other entities also made 1 purchase worth about $2.5M in the last 12 months, not counted above.
The largest open-market purchase in the last two years was 140,000 shares by James B. Tananbaum (Director, 10% Owner) at an average $18.00 on August 10, 2026, about $2.5M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 7.33M | $106.74M | - | |
| 10% | 3.41M | $49.75M | - | |
| 10% | 3.41M | $49.75M | - | |
| 10% | 2.09M | $30.52M | - | |
| 10% | 2.09M | $30.52M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | James B. Tananbaum59 | Director, 10% Owner | Buy | 140,000 | $18.00 | $2,520,000.00 | +7.5% | |
| Aug 10, 2026 | Foresite Capital Management V, LLC | 10% Owner | Buy | 140,000 | $18.00 | $2,520,000.00 | +7.5% |